E-LIB Suche - Ergebnisse für: Ferreri, A. J. M.

1

Erratum to "Clozapine treatment of a borderline personality..:

Ferreri, M.M. ; Loze, J.-Y. ; Rouillon, F..
European Psychiatry. 19 (2004) 6 - p. 393-393 , 2004

Link: https://doi.org/10.1016/..

2

Relevance of intraocular involvement in the management of p..:

American Journal of Ophthalmology. 135 (2003) 5 - p. 755 , 2003

Link: https://doi.org/10.1016/..

3

Radioimmunotherapy versus autologous hematopoietic stem cel..:

Ladetto, M. ; Tavarozzi, R. ; Zanni, M....
Annals of Oncology. 35 (2024) 1 - p. 118-129 , 2024

Link: https://doi.org/10.1016/..

4

Primary central nervous system lymphomas: EHA–ESMO Clinical..:

Ferreri, A.J.M. ; Illerhaus, G. ; Doorduijn, J.K....
Annals of Oncology. 35 (2024) 6 - p. 491-507 , 2024

Link: https://doi.org/10.1016/..

5

Exposure to obinutuzumab does not affect outcomes of SARS‐C..:

Pinto, A. ; Caltagirone, M. ; Battista, M....
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

6

Toward a feminist housing commons? Conceptualising care - (..:

Fernández Arrigoitia, Melissa ; Ferreri, M. ; Hudson, J...
Housing, Theory and Society. 40 (2023) 5 - p. 660-678 , 2023

Link: https://doi.org/10.1080/..

7

A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PR..:

Davies, A. J. ; Zucca, E. ; Ceriani, L....
Hematological Oncology. 41 (2023) S2 - p. 48-50 , 2023

Link: https://doi.org/10.1002/..

8

THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTAC..:

Ferreri, A. J. M. ; Sassone, M. C. ; Cangi, M. G....
Hematological Oncology. 41 (2023) S2 - p. 106-107 , 2023

Link: https://doi.org/10.1002/..

9

P1239: TISLELIZUMAB, A PD-1 INHIBITOR FOR RELAPSED/REFRACTO..:

Bachy, E. ; Savage, K. J. ; Huang, H....
HemaSphere. 6 (2022) - p. 1124-1125 , 2022

Link: https://doi.org/10.1097/..

10

P1208: CHARACTERISTICS AND CLINICAL OUTCOMES OF PATIENTS WI..:

Chiattone, C. ; Civallero, M. ; Fischer, T....
HemaSphere. 6 (2022) - p. 1094-1095 , 2022

Link: https://doi.org/10.1097/..

11

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLEC..:

Fowler, N. H. ; Dickinson, M. ; Martinez‐Lopez, J....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

12

SAFETY AND EFFICACY OF THE "CARMEN" REGIMEN, A NEW DOSE‐DEN..:

Ferreri, A. J. M ; Angelillo, P ; Erbella, F...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

13

PROGNOSTIC FACTORS, MANAGEMENT AND OUTCOME OF AN INTERNATIO..:

Ferreri, A. J.M. ; Tarantino, V. ; Cabras, G....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

14

Quantitative muscle mass biomarkers are independent prognos..:

Leone, R. ; Sferruzza, G. ; Calimeri, T....
European Journal of Radiology. 143 (2021) - p. 109945 , 2021

Link: https://doi.org/10.1016/..

15

SARS‐COV‐2 INFECTION IN 50 PATIENTS WITH PRIMARY CNS LYMPHO..:

Ferreri, A. J. M. ; Steffanoni, S. ; Calimeri, T....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..